Treatment of erythrodermic psoriasis: From the medical board of the National Psoriasis Foundation
- 1 April 2010
- journal article
- review article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 62 (4), 655-662
- https://doi.org/10.1016/j.jaad.2009.05.048
Abstract
No abstract availableKeywords
Funding Information
- National Psoriasis Foundation
This publication has 34 references indexed in Scilit:
- A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunityBritish Journal of Dermatology, 2006
- Methotrexate and ciclosporin combination for the treatment of severe psoriasisClinical and Experimental Dermatology, 2006
- Combination therapy to treat moderate to severe psoriasisJournal of the American Academy of Dermatology, 2004
- Erythroderma in adults: a report of 80 casesInternational Journal of Dermatology, 2004
- Infectious complications of erythrodermic psoriasisJournal of the American Academy of Dermatology, 1996
- Combination of etretinate with cyclosporine in the treatment of severe recalcitrant psoriasisJournal of the American Academy of Dermatology, 1994
- Management of Erythrodermic Psoriasis with Low-Dose CyclosporinDermatology, 1993
- Cyclosporine and methotrexate: A dangerous combinationJournal of the American Academy of Dermatology, 1990
- Combination Therapy Ciclosporin-Etretinate Effective in Erythrodermic PsoriasisDermatology, 1989
- Combination therapy for psoriasis with methotrexate and etretinateJournal of the American Academy of Dermatology, 1986